Introduction
Fatty acids of nutritional relevance can be grouped as saturated fatty acids (SAFAs), monounsaturated fatty acids (MUFAs), and polyunsaturated fatty acids (PUFAs). These fatty acids are found in commonly consumed dietary fats such as coconut fat, rich in SAFAs; olive oil, rich in MUFAs [mainly oleic acid (OLA, 18:1n9)]; fish oil, rich in n3-PUFAs [mainly eicosapentaenoic acid (EPA, 20:5n3) and docosahexaenoic acid (DHA, 22:6n3)]; sunflower oil, rich in n6-PUFAs [mainly linoleic acid (LA, 18:2n6)]; and margarine, a mix of n6-PUFAs, MUFAs, and SAFAs.
Current dietary recommendations for chronic disease prevention are to focus on the quality of dietary fat consumed favoring MUFA and PUFA sources while limiting SAFA-rich diets [
1‐
3]. However, high intake of n6-PUFAs results in a shift of the n3/n6 PUFA ratio towards a more pronounced n6-PUFAs ratio, which has been associated with the pathogenesis of various chronic inflammatory diseases [
4]. Another alternative to reduce SAFA intake is consumption of margarine with a higher PUFAs’ and MUFAs’ content; however, the benefits of margarine consumption are not conclusive [
5‐
7]. Thus, a better understanding of the roles fatty acids play on mechanisms underpinning health and disease is needed.
Besides providing an energy source for metabolic processes, fatty acids have the potential to act as regulators of gene expression of enzymes in lipid homeostasis, fatty acid metabolism for energy homeostasis, and inflammation via nuclear hormone receptor (NHR)-mediated signaling [
8]. Fatty acids, as well as specific synthetic ligands can activate NHR-mediated signaling such as retinoid X receptor (RXR)-, liver X receptor (LXR)-, peroxisome proliferator-activated receptors (PPARs)-, and retinoic acid receptor (RAR)-mediated signaling. These receptors are major regulators of genes associated with fat and energy metabolism [
9‐
13].
A further important fate of essential fatty acids is their incorporation into phospholipids, which are key components of cell membranes [
8,
14]. In humans, the phospholipid fatty acid composition is well associated with dietary fat intake [
15‐
17]. The composition of phospholipids adapts depending of the type of dietary fatty acids consumed because of a constant turnover. This adaptation following fatty acid change could also alter the functionality and stability of affected cellular membranes [
8,
18]. The availability of fatty acids to be incorporated into phospholipids also depends on the enzymatic activity of fatty acid-metabolizing enzymes [
19].
The enzymes stearoyl-desaturase 1 (SCD1) and elongase 6 (ELOVL6) are key regulators of MUFA and SAFA content in phospholipids [
20,
21]. SCD1 desaturates stearic acid (STE, 18:0) or palmitic acid (PAL, 16:0) to 18:1n9 or palmitoleic acid (PAM, 16:1n7), respectively. ELOVL6 further elongates 16:0–18:0 and 16:1n7 to vaccenic acid (VAC, 18:1n7) [
21]. Our previous studies in mice have shown that diet modulates the hepatic gene expression of SCD1. A diet rich in sunflower oil, and its major fatty acid constituents (n6-PUFAs) was an effective suppressor of the hepatic SCD1 and ELOVL6 expression [
22]. This suppression was also observed in phospholipid composition concomitantly with a significant reduction of their metabolic products measured in cellular membranes of liver tissue, in particular MUFAs [
22]. The mechanism of suppression of SCD1 and ELOVL6 by dietary fats with a high n6-PUFA content is still not fully understood, while it is well known that dietary n3-PUFAs also have a pronounced suppressive effect on the expression of these enzymes [
23]. Regulation of the gene expression of SCD1 and ELOVL6 requires activation of RXR, a nuclear hormone receptor activated mainly by forms of vitamin A [
24‐
26].
A novel theory is that CYP26A1, a well-known target gene of RAR-mediated signaling [
27], is also implicated as a feedback mechanism in degradation of the endogenous ligands of the RARs, all-
trans-retinoic acid towards less active hydroxy-/oxo-retinoic acids [
27,
28]. The clearance of the endogenous RXR ligand [
29] is likely also due to CYP26A1, an enzyme induced by 22:6n3, one of the main n3-PUFAs in fish oil [
29,
30]. As a logical consequence, the activity of RXR is dependent on the availability of its natural derived ligands, which in turn is regulated by the enzymatic activity of CYP26A1. These mechanisms could explain the suppressive effect of fish oil on the gene expression of SCD1 and ELOVL6 [
31], but this needs testing.
The aim of this study was (1) to determine the impact of nutritionally relevant dietary fats (coconut fat, margarine, olive oil, sunflower oil, and fish oil) on the hepatic gene expression of major fat metabolizing enzymes and on ratios and amounts of major fatty acids present in plasma; (2) to evaluate the hepatic expression of major fat metabolizing enzymes SCD1 and ELOVL6 and their activity represented by major substrate vs. product ratios; and (3) to investigate the hepatic gene expression of CYP26A1 after treatment with synthetic ligands of specific nuclear hormone receptors (NHRs) such as liver X receptor (LXR), peroxisome proliferator-activated receptors (PPARs), RXR, and RARs. CYP26A1 is considered as a possible candidate for indirect regulation of the hepatic gene expression of SCD1 and ELOVL6. We hypothesized that these mechanisms are modulated by retinoid-mediated signaling.
Materials and methods
Animal experiments were performed at the Laboratory Animal Core Facility of the University of Debrecen (Debrecen, Hungary) in accordance with the ethical guidelines of Hungary. Ethical approval was obtained from the Hungarian Animal Experimental Scientific Ethics Council in Budapest (registration 25/2006/DE MÁB). The Animal Experimentation Commission of University of Debrecen also approved the experiment.
Animal studies
Six-to-eight-week-old female standard C57BL6 (Strain Code 027) mice, purchased from Charles River (Budapest, H), were first fed ad libitum for 2 weeks with regular chow (VRF1, Altromin GmbH, Lage, D).
Dietary fats and oil supplementation study
After the acclimatization period of 2 weeks, the animals were divided into five groups (total
n = 30, 6 animals per diet group) and were assigned to each receive a different type of dietary fat for 4 weeks. The sample size was based on our previous experiments that tested the effect of ligand and dietary fats on SCD1 expression [
22,
24]. These studies were powered, 99% and 72%, respectively, to detect a five- and threefold increase in SCD1 expression in experimental vs. control conditions with a level of
p < 0.05.
Oil and fat supplementation diets
The experimental diets were formulated according to Bonilla et al. [
32] and contained 415 g/kg diet (41.5%) wheat starch (Weizenstärke FOODSTAR, provided by Kröner-Stärke Ibbenbüren, D), 280 g/kg diet (28.0%) sucrose (purchased from a local supermarket), 180 g/kg diet (18.0%) casein from bovine milk (purchased from Sigma-Aldrich, Budapest, H), and 20 g/kg diet (2%) cellulose VIVAPUR (provided by JRS Pharma GmbH & Co. KG, Rosenberg, D). The content of minerals was 45 g/kg diet (4.5%) (Mineral-Spurenelemente-Vormischung C1000). The vitamin content was 10 g/kg diet (1%) (Vitamin-Vormischung C1000) and was purchased from Altromin GmbH (Lage, D). The source of dietary fat in each experimental diet differed, while the content remained the same in each diet at 50 g fat/kg diet (5.0%) which is considered a normal fat content in laboratory animal-based feeding studies [
32]. The fat sources were sunflower oil, fish oil, coconut fat, and olive oil (provided by Henry Lamotte, Bremen, D) and margarine (purchased from a local supermarket). The carbohydrate/protein/fat ratio in percent was 69.5%/18%/5%, and other nutrients made up the remaining 7.5%. Table
1 displays the fatty acid composition of each diet. The composition of fatty acids for all dietary fats and of phospholipids was analyzed by GC. All values were normalized to coconut fat (= 1) to compare diet groups with each other and to compare GC values of diet and phospholipids to each other.
Table 1
Composition of selected fatty acids of experimental diets analyzed by GC and displayed as weight %
SAFA | 93.35 | 31.34 | 15.24 | 11.59 | 31.58 |
16:0 | 18.21 | 21.24 | 11.9 | 6.47 | 20.56 |
18:0 | 20.47 | 3.51 | 2.7 | 4.07 | 4.11 |
MUFA | 2.43 | 44.58 | 73.56 | 19.98 | 24.77 |
16:1n7 | 0.06 | 0.24 | 1.21 | 0.02 | 8.3 |
18:1n7 | 0.1 | 1.92 | 1.79 | 0.47 | 3.22 |
18:1n9 | 2.16 | 40.89 | 70.4 | 19.44 | 10.51 |
20:1n9 | 0.08 | 0.85 | 0.17 | 0.05 | 1.82 |
n6-PUFA | 3.7 | 18.97 | 10.63 | 68.17 | 5.94 |
18:2n6 | 3.23 | 18.69 | 10.52 | 67.86 | 3.51 |
18:3n6 | < 0.001 | 0.01 | < 0.001 | < 0.001 | 0.26 |
20:3n6 | < 0.001 | < 0.001 | < 0.001 | 0.04 | 0.19 |
20:4n6 | < 0.001 | 0.02 | < 0.001 | 0.06 | 1.02 |
22:4n6 | 0.02 | 0.02 | < 0.001 | < 0.001 | 0.11 |
22:5n6 | < 0.001 | 0.03 | < 0.001 | < 0.001 | 0.46 |
n3-PUFA | 0.32 | 5.03 | 0.49 | 0.20 | 37.14 |
18:3n3 | 0.29 | 4.79 | 0.45 | 0.17 | 1.29 |
18:4n3 | < 0.001 | 0.14 | 0.02 | < 0.001 | 3.09 |
20:5n3 | < 0.001 | 0.03 | 0.02 | 0.03 | 16.11 |
22:5n3 | 0.02 | < 0.001 | < 0.001 | < 0.001 | 2.77 |
22:6n3 | 0.02 | 0.02 | < 0.001 | 0 | 13.72 |
Nuclear hormone receptor-specific ligand study [24]
After the acclimatization period of 2 weeks, animals (total n = 42, 6 animals per treatment group, 7 treatment groups including vehicle) were gavaged daily for 1 week with nuclear hormone receptor-specific synthetic ligands dissolved in 25% Cremophor EL (Sigma-Aldrich, Budapest, H)/water (v/v). The base diet of these animals was standard chow (VRF1, Altromin, D). The vehicle (Cremophor EL) was applied at 5 ml/kg body weight (b. w.). Rosiglitazone a PPARγ ligand was bought from Biomol (Butler Pike, USA), applied dosage 3 mg/kg b.w. [
33] and LG268 a RXR ligand, applied dosage 30 mg/kg b.w. [
34] was a gift from Ligand Pharmaceuticals (San Diego, Calif., USA). AM580 (RAR ligand, applied dosage 10 mg/kg b.w.) [
35], GW7647 (PPARα ligand, applied dosage 3 mg/kg b.w.) [
36], and GW0742 (PPAR β/δ ligand, applied dosage 5 mg/kg b.w.) [
37], were purchased from Biotrend Chem. GmbH (Köln, D) and T0901317 (LXR ligand, applied dosage 20 mg/kg b.w.) [
38] from Cayman Chemical Company (Tallinn, EST).
Animal handling
All mice had free access to water and food for the duration of the experiment. They were kept at 22 °C room temperature with a 12 h day/night cycle. All animals were killed by anaesthesia with halothane. Blood collection was carried out by cardiac puncture. The blood was centrifuged for 10 min and plasma was stored at − 80 °C. The mice were dissected, and liver samples were weighed and immediately frozen in liquid nitrogen and later stored at − 80 °C.
RNA isolation from liver and QRT-PCR
Total RNA was isolated from liver and quantified by QRT-PCR (quantitative real-time PCR). Samples of liver tissue (50 mg) were homogenized in Trizol (10 mg tissue/100 µl Trizol, Sigma-Aldrich, Budapest, H) and extracted with chloroform (20 µl/100 µl Trizol). The aqueous phase was mixed with 700 µl of ethanol (70% v/v) and loaded on the RNA isolation column (GenElute Mammalian Total RNA Miniprep Kit, Sigma-Aldrich, Budapest, Hungary). RNA was isolated from tissue according to the protocol of Sigma-Aldrich and eluted in nuclease free water. Concentration and purity of RNA were measured by Nanodrop (Thermo, Budapest, Hungary). cDNA was obtained by reverse transcription (10 min 25 °C, 120 min 42 °C, 5 min 72 °C) and amplified via QRT-PCR (40 cycles: 12 s 94 °C, 45 s 60 °C, 60 s 94 °C). The primer and probe for the expression analysis (Taq-Man-Gene Expression Assay) as well as the quantitative real-time PCR detection system (ABI-PRISM, 7900HT Sequence Detection System) were purchased from Applied Biosystems (Budapest, Hungary). The expression of genes was normalized to cyclophilin A (house-keeping gene): primer 77“+”5´-CGATGACGAGCCCTTGG-3´, primer 142”-“5´-TCTGCTGTCTTTGGAACTTTGTC-3´, probe (69+ , 96 +): FAM-CGCGTCTCCTTCGAGCTGTTTGCA, quencher tetramethylrhodamine (TAMRA). The amplification signal was detected and analyzed by the SDS2.1 program from Applied Biosystems, Budapest, Hungary. The expression of the house-keeping gene was stable and was not influenced by dietary treatment. The hepatic gene expression of target genes SCD1, ELOVL6, and CYP26A1 was normalized to coconut fat supplementation diet (= 1).
Fatty acid analysis by gas chromatography (GC)
Food and plasma samples were analyzed by GC. Frozen samples were thawed and the pentadecanoylphosphatidylcholine (L-α phosphatidylcholine, dipentadecanoyl, Sigma-Aldrich, Budapest, Hungary) internal standard was added. Lipids were extracted by the addition of 3 ml chloroform and 1 ml methanol according to the method of Folch [
39]. The mixture was vortexed at 3000 rpm for 15 min. The lower layer was then aspirated into vials and evaporated under an N
2 stream. Lipid extracts were reconstituted in 70 µl chloroform and lipid classes were separated by thin-layer chromatography (TLC). The solvent mix for TLC of plasma lipids was as follows: hexane: diethyl ether: chloroform: acetic acid (21:6:3:1, v/v). The bands were stained with dichlorofluorescein and removed by scraping and transesterified in 1 ml of 3 N HCl in methanol solution (3 N methanolic HCl, Supelco, Budapest, H) at 84 °C for 45 min [
40]. For plasma samples, the phospholipid fraction was analyzed after TLC separation. Fatty acids were analyzed by high-resolution capillary GC using a Finnigan 9001 gas chromatograph (Finnigan/Tremetrics Inc., Austin, TX, USA) with split injection (ratio 1:25), an automatic sampler (A200SE; CTC Analytic, Zwingen, CH, USA), and a flame ionization detector with a DB-23 cyanopropyl column of 40 m length (J&W Scientific, Folsom, CA, USA). The temperature program was set to the following parameters: temperature of the injector at 80 °C/min up to 280 °C, temperature of the detector at 280 °C, temperature of the column area at 60 °C for 0.2 min, temperature increase by 40 °C/min up to 180 °C, 5 min isothermal period, temperature increase by 1.5 °C/min up to 200 °C, 8.5 min isothermal period, temperature increase by 40 °C/min up to 240 °C, and 13 min isothermal period. The constant linear velocity was 0.3 m/s (referred to 100 °C). Peak identification was confirmed by comparison with authentic mixtures of weighed fatty acid methylesters (GLC-463: Nu-Chek Prep, Elysian, MN, USA; and Supelco 37 FAME Mix: Supelco, Bellefonte, PA, USA). Individual fatty acid responses determined from weighed standards were used to calculate the percentage by weight for each fatty acid (between 12 and 24 carbon atoms) based on the area under the curve. Values were normalized to coconut fat (= 1) and compared with the other diet groups. The normalized values of enzyme-specific fatty acids for SCD1 and ELOVL6 analyzed by GC are displayed for diet and phospholipids. Normalization of values of the enzyme-specific fatty acid profile in diet and phospholipids enabled a direct comparison.
Graphical analysis
Network graphical analysis was created using the mixOmics package in R (3.5 version) [
41]. The resulting color codes for the mouse data as well as the food data were incorporated into a self-constructed graphic representation.
Statistical analysis
Results are shown as mean and standard error of mean. The effect of diet (comparing all diet groups to each other) was analyzed using the Kruskal–Wallis test followed by paired analysis. All statistical analyses were done using SPSS (15.0) software (SPSS Inc., Chicago, USA). Statistically significance was accepted at p < 0.05.